
Halozyme Therapeutics HALO
$ 62.61
-0.74%
Annual report 2025
added 02-17-2026
Halozyme Therapeutics P/S Ratio 2011-2026 | HALO
Annual P/S Ratio Halozyme Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.91 | 7.23 | 5.73 | 10.4 | 11.3 | 23 | 14.3 | 15.1 | 8.28 | 9.8 | 8.26 | 23.3 | 32.9 | 18.6 | 19.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 32.9 | 5.73 | 14.3 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.8 | 5.33 % | $ 9.14 B | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.63 | -1.22 % | $ 16.5 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 88.34 | -3.22 % | $ 27.2 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
11 | $ 316.2 | -4.28 % | $ 41.4 B | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Burford Capital Limited
BUR
|
6.35 | $ 4.44 | -0.67 % | $ 730 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
argenx SE
ARGX
|
311 | $ 743.15 | -0.68 % | $ 25 B | ||
|
Завод ДИОД
DIOD
|
1.28 | - | - | - | ||
|
Фармсинтез
LIFE
|
5.39 | - | - | - | ||
|
Aptorum Group Limited
APM
|
105 | $ 0.89 | - | $ 4.85 M | ||
|
Applied Therapeutics
APLT
|
54.1 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Teligent, Inc.
TLGT
|
0.111 | - | -13.85 % | $ 16.1 M | ||
|
Cerus Corporation
CERS
|
2.12 | $ 1.8 | -2.7 % | $ 343 M | ||
|
AbbVie
ABBV
|
24.1 | $ 202.28 | -2.11 % | $ 358 B | ||
|
Aquestive Therapeutics
AQST
|
10.5 | $ 4.04 | -1.28 % | $ 432 M | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Viela Bio, Inc.
VIE
|
36.6 | - | - | $ 2.91 B | ||
|
Coherus BioSciences
CHRS
|
5.36 | $ 1.63 | -2.69 % | $ 191 M | ||
|
AbCellera Biologics
ABCL
|
12.8 | $ 3.32 | -2.06 % | $ 992 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
2.65 | $ 8.12 | -1.22 % | $ 222 M | ||
|
Ardelyx
ARDX
|
3.98 | $ 5.8 | -2.93 % | $ 1.4 B |